Biotechnology

Filter

Current filters:

None

Popular Filters

1920 to 1944 of 2409 results

FDA calls for Biovest to conduct another Ph III trial of BiovaxID in NHL

16-08-2012

US biotech firm Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

BiotechnologyBiovaxIDBiovest InternationalOncologyRegulationResearch

Arrowhead Research Corp improving focus, say Edison analysts

16-08-2012

Last year's acquisition of Roche's RNAi (RNA interference) business (The Pharma Letter October 25, 2011)…

AdipotideAnti-viralsArrowhead ResearchBiotechnologyFinancialMetabolicsOncologyResearch

AusBiotech supports discussion paper on Australian national research investment plan

15-08-2012

Biotechnology trade group AusBiotech, responding to the Australian federal government's discussion paper…

Asia-PacificBiotechnologyFinancialResearch

Low-dose Ampyra fails in multiple sclerosis study, says Acorda

15-08-2012

USA-based biotech firm Acorda Therapeutics (Nasdaq: ACOR) has announced top line results from a post-marketing…

Acorda TherapeuticsAmpyraBiotechnologyMetabolicsNeurologicalPharmaceuticalResearch

Cortex and Pier Pharma in all-share merger

15-08-2012

USA-based neuroscience company Cortex Pharmaceuticals (OTCBB: CORX) and privately held biotech firm Pier…

BiotechnologyCortex PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalPier Pharmaceuticals

EMA explains EU incident management plan for human medicines

14-08-2012

Earlier this week, the European Medicines Agency published the European Union regulatory network incident…

BiotechnologyEuropePharmaceuticalRegulation

Pluristem links with Cato Research for PLX-PAD trial in IC indication in Europe

14-08-2012

Israeli biotech company Pluristem Therapeutics (TASE: PLTR), a developer of placenta-based cell therapies,…

BiotechnologyCardio-vascularCato ResearchPluristem TherapeuticsPLX-PADResearch

South and Central America API market closing gap on northern neighbors

13-08-2012

The market for active pharmaceutical ingredients (API) t in the Americas was worth a staggering $46 billion…

BiotechnologyGenericsMarkets & MarketingNorth AmericaSouth America

Elan to spin-off discovery science and Neotope Biosciences

13-08-2012

Ireland-headquartered Elan Corp (NYSE: ELN) this morning revealed that its board of directors has approved…

BiotechnologyElanFinancialNeotope BiosciencesPharmaceutical

Crucell and Scripps Research discover broad-spectrum antibodies against influenza B

12-08-2012

In what is described as a landmark discovery, researchers from Crucell Holland, which became wholly-owned…

Anti-viralsBiotechnologyCrucellJohnson & JohnsonPharmaceuticalResearchVaccines

Ganitumab demise a disappointment for pancreatic cancer community

12-08-2012

There was bad news not just for US biotech giant Amgen (Nasdaq: AMGN), which last week announced that,…

AmgenBiotechnologyganitumabNovartisOncologyPharmaceuticalResearch

US health care reform looks to squeeze players up and down the value chain

09-08-2012

This summer's landmark Supreme Court decision to uphold the USA's Patient Privacy and Affordable Care…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalRegulationResearch

Pharma companies accused of "putting profits ahead of medical discoveries"

09-08-2012

Data indicate that the widely touted "innovation crisis" in pharmaceuticals is a myth. The real innovation…

BiotechnologyFinancialPharmaceuticalResearch

Amgen halts ganitumab study on little hope of success

09-08-2012

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, late yesterday revealed…

AmgenBiotechnologyganitumabgemcitabine HclOncologyResearch

World's first (official) biosimilar antibody goes to reumatoid arthritis

09-08-2012

The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory…

BiotechnologyCellTrionGenericsGlobalinfliximabJohnson & JohnsonMarkets & MarketingRegulationRemicadeRemsima

MEI Pharma to acquire S*BIO's pracinostat

08-08-2012

US cancer drug developer MEI Pharma (Nasdaq: MEIP) has entered into a definitive asset purchase agreement…

BiotechnologyMEI PharmaMergers & AcquisitionsOncologyPharmaceuticalpracinostatS*BIO

PharmaEngine and Nanobiotix sign Asia-Pacific deal for NBTXR3

08-08-2012

French nano-medicines group Nanobiotix has entered into a strategic partnership with PharmaEngine (TWO:…

Asia-PacificBiotechnologyLicensingNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngine

Pluristem cleared to start Phase I/II PLX cell study for muscle regeneration in Germany

08-08-2012

In a second piece of good news this week, Israeli biotech company Pluristem Therapeutics (TASE: PLTR)…

BiotechnologyEuropePluristem TherapeuticsPLX cellsRegulationResearch

ViroPharma gets FDA backing for industrial scale Cinryze manufacturing

07-08-2012

US biotech firm ViroPharma (Nasdaq: VPHM) says that the US Food and Drug Administration has approved…

BiotechnologyCinryzeNorth AmericaProductionRegulationReproductiveViroPharma

Pluristem's PLX cells save cancer patient suffering bone marrow failure

06-08-2012

Shares of Israel's Pluristem Therapeutics (TASE: PLTR), a leading developer of placenta-based cell therapies,…

BiotechnologyOncologyPluristem TherapeuticsPLX cellsResearch

1920 to 1944 of 2409 results

Parexel

Parexel

Back to top